This Edition
Analysis
Featured Analysis
Articles
Current Editions
Data Graphics
Podcasts & Webcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
China Healthcare Summit
Bio€quity Europe
The BioCentury Show
My Workspace
About BioCentury
Company Overview
Management
Editorial & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Trial
Subscribe
Advertising & Sponsorship
Career Opportunities
Customer Resource Center
ARTICLE | Company News
FDA extends review of Samsung Bioepis' trastuzumab biosimilar
Sandi Wong
November 9, 2018 1:14 AM GMT
Access this Article
Request a Trial
Purchase This Article
Subscribers Log in
BCIQ Company Profiles
Biogen Inc.
Genentech Inc.
Samsung BioLogics Co. Ltd.
Roche
BCIQ Company Profiles
Biogen Inc.
Genentech Inc.
Samsung BioLogics Co. Ltd.
Roche
